Drug acquisition-cost intelligence
For pharmacy & clinic buyers: the historical pharmacy acquisition-cost trend (NADAC), generic-equivalent cost comparison, and Medicare Part D coverage. NADAC is what pharmacies pay — an acquisition cost, not a retail or cash price (for consumer cash prices, use GoodRx or your plan).
Source: CMS NADAC · methodology. Drug-pricing intelligence, not medical advice and not the price you’ll pay at a pharmacy.
💸 Biggest brand→generic savings →
Where switching to the generic cuts acquisition cost most.
⚠ Drugs currently in shortage →
FDA-reported shortages with acquisition cost + generic options.
← All drugs
Therapeutic class: Antihistamines for topical use
0 drugs with real acquisition-cost data in this class.
0 shown · 0 drugs with real acquisition-cost history
No matches. Try a generic name (e.g. “atorvastatin”), ingredient, or class.